Bain Capital Life Sciences Investors, LLC Pharvaris N.V. Transaction History
Bain Capital Life Sciences Investors, LLC
- $557 Million
- Q3 2024
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 3,303,381 shares of PHVS stock, worth $61.1 Million. This represents 10.98% of its overall portfolio holdings.
Number of Shares
3,303,381
Previous 3,303,381
-0.0%
Holding current value
$61.1 Million
Previous $62.1 Million
1.49%
% of portfolio
10.98%
Previous 12.7%
Shares
4 transactions
Others Institutions Holding PHVS
# of Institutions
51Shares Held
39.6MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$139 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$81.4 Million53.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$79.4 Million65.3% of portfolio
-
Viking Global Investors LP3.65MShares$67.6 Million0.26% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$62.8 Million6.51% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $625M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...